Cargando…

Preexisting Atrial Fibrillation Associated with Higher Mortality in Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: Analysis of the National Inpatient Sample

BACKGROUND: The purpose of this study was to investigate the prevalence of preexisting atrial fibrillation (AF) in patients with MRSA-BSI during a three-year period and the impact of preexisting AF on MRSA-BSI outcomes. METHODS: This was a retrospective analysis performed using the National Inpatien...

Descripción completa

Detalles Bibliográficos
Autores principales:	McCann, Timothy, Fatuyi, Michael, Patel, Neha, Sharath, Deepali B., Patel, Anar S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325627/ https://www.ncbi.nlm.nih.gov/pubmed/35911626 http://dx.doi.org/10.1155/2022/8965888

Ejemplares similares

2397. Infective Endocarditis is Associated With Higher Mortality and Worse Clinical Outcomes in Patients Hospitalized with a Concomitant Diagnosis of Heart Failure
por: Sharath, Deepali Boothankad, et al.
Publicado: (2023)

Cutaneous cryptococcal infection: Initial manifestation of acquired T-cell immunodeficiency due to malignant thymoma
por: McCann, Timothy, et al.
Publicado: (2022)

1208. Impact of Admission to an Inpatient Infectious Disease Unit on Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
por: Mirza, Zainab Farooqui, et al.
Publicado: (2018)

2490. Improving Hepatitis C Continuum of Care in an Outpatient Internal Medicine Population
por: Sharath, Deepali Boothankad, et al.
Publicado: (2023)

Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Hospitalizations: National Inpatient Sample, 2016–2019
por: Klein, Eili Y, et al.
Publicado: (2021)

Transesophageal Echocardiography vs. Transthoracic Echocardiography for Methicillin-Sensitive Staphylococcus aureus and Methicillin-Resistant Staphylococcus aureus Endocarditis
por: Henriquez, Elvis, et al.
Publicado: (2023)

2793. Clinical Outcomes of Combination Therapy with Daptomycin and Ceftaroline for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection
por: Chapin, Ryan W, et al.
Publicado: (2023)

Emergence of Livestock-Associated Methicillin-Resistant Staphylococcus aureus Bloodstream Infections in Denmark
por: Larsen, Jesper, et al.
Publicado: (2017)

Genomic epidemiology of methicillin-resistant and -susceptible Staphylococcus aureus from bloodstream infections
por: Smith, Joshua T., et al.
Publicado: (2021)

Increases in methicillin-sensitive Staphylococcus aureus bloodstream infection incidence, 2016–2019
por: Jackson, Kelly, et al.
Publicado: (2022)

A study of the prevalence of methicillin-resistant Staphylococcus aureus in dermatology inpatients
por: Vijayamohan, N., et al.
Publicado: (2014)

2452. Treatment and Outcomes of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
por: Hadid, Hind, et al.
Publicado: (2018)

2250. Combination Vancomycin Plus Cefazolin for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
por: Jorgensen, Sarah C J, et al.
Publicado: (2019)

Genomic Epidemiology and Characterization of Methicillin-Resistant Staphylococcus aureus from Bloodstream Infections in China
por: Jin, Ye, et al.
Publicado: (2021)

191. When Staph Is Not Solo: Polymicrobial Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
por: Escalona, Angelica, et al.
Publicado: (2023)

Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections — United States
por: Kourtis, Athena P., et al.
Publicado: (2019)

2129. When Is Methicillin-resistant Staphylococcus aureus not Methicillin-resistant Staphylococcus aureus?
por: Gitman, Melissa R, et al.
Publicado: (2019)

Molecular Epidemiology and Antimicrobial Resistance of Methicillin-Resistant Staphylococcus aureus Bloodstream Isolates in Taiwan, 2010
por: Chen, Chih-Jung, et al.
Publicado: (2014)

1222. Risk Factors and Outcomes for Daptomycin Nonsusceptible Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
por: Hadid, Hind, et al.
Publicado: (2018)

1073. Predictors of Vancomycin Switch or Escalation in Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infection
por: Lagnf, Abdalhamid M, et al.
Publicado: (2018)

Comparison of Clinical Outcomes for Glycopeptides and Beta-Lactams in Methicillin-Susceptible Staphylococcus Aureus Bloodstream Infections
por: La, Yeon Ju, et al.
Publicado: (2022)

Everybody nose: molecular and clinical characteristics of nasal colonization during active methicillin-resistant Staphylococcus aureus bloodstream infection
por: Reategui Schwarz, Erika, et al.
Publicado: (2022)

Methicillin-Resistant Staphylococcus aureus
por: Tenover, Fred C., et al.
Publicado: (2004)

Methicillin-Resistant Staphylococcus Aureus
por: Al-Quorain, Abdulaziz
Publicado: (2016)

Methicillin-Susceptible ST398 Staphylococcus aureus Responsible for Bloodstream Infections: An Emerging Human-Adapted Subclone?
por: Valentin-Domelier, Anne-Sophie, et al.
Publicado: (2011)

Combination Vancomycin/Cefazolin (VAN/CFZ) for Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections (BSI)
por: Trinh, Trang D, et al.
Publicado: (2017)

High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus
por: San-Juan, Rafael, et al.
Publicado: (2016)

The Safety and Economic Impact of Cefazolin versus Nafcillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections
por: Flynt, Lauren K., et al.
Publicado: (2017)

Methicillin-Resistant Staphylococcus aureus Bloodstream Infections and Injection Drug Use, Tennessee, USA, 2015–2017
por: Parikh, Meghana P., et al.
Publicado: (2020)

Sequence type 8 as an emerging clone of methicillin-resistant Staphylococcus aureus causing bloodstream infections in Taiwan
por: Chen, Pao-Yu, et al.
Publicado: (2021)

Multicenter Cohort Study of Ceftaroline Versus Daptomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection
por: Zasowski, Evan J, et al.
Publicado: (2021)

1827. Comparison of clinical outcomes for glycopeptides and beta-lactams in methicillin-susceptible Staphylococcus aureus bloodstream infections
por: La, Yeon Ju, et al.
Publicado: (2022)

In-vitro Activity of Delpazolid and Comparator Agents Against Methicillin-resistant Staphylococcus aureus Involved in Bloodstream Infection
por: Park, Jeong Su, et al.
Publicado: (2023)

Management of Staphylococcus aureus Bloodstream Infections
por: Kimmig, Aurelia, et al.
Publicado: (2021)

1712. Reduction of Neonatal Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections After Implementation of a S. aureus Screening and Decolonization Protocol
por: Weber, Rachel, et al.
Publicado: (2023)

Methicillin-Resistant Staphylococcus Aureus: A Very Rare Cause of Meningitis
por: Mehmood, Maham A, et al.
Publicado: (2020)

Genetic and phenotypic diversity of methicillin-resistant Staphylococcus aureus among Japanese inpatients in the early 1980s
por: Zuo, Hui, et al.
Publicado: (2021)

The Impact of Concomitant Empiric Cefepime on Patient Outcomes of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections Treated With Vancomycin
por: Zasowski, Evan J, et al.
Publicado: (2019)

162. Identifying Determinants of Therapeutic Switch to Linezolid among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
por: Nair, Rajeshwari, et al.
Publicado: (2019)

Epidemiological characteristics of methicillin-resistant Staphylococcus aureus isolates from bloodstream cultures at University Hospital in the Czech Republic
por: Neradova, Katerina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g549do6rqvhd297thdr290gsak